Home

Pharma China Web Edition

Pharma China Archives

Online Databases

Subscription/Order/Info

Event Calendar

China Pharma Providers

About Us

	News     The Market     Industry News     Regulatory News     General Health     Legal/IPR News     Product/R&D News     API/Bulk Drug News     People in the News     Other News     Top News Worldwide Feature articles     Featured News     Editorials     Commentaries     Expert Opinions     Interviews     Case Studies     Company Profiles     Editor´s Picks Full Text Title

The Market Industry News Regulatory News General Health Legal/IPR News Product/R&D News API/Bulk Drug News People in the News Other News Top News Worldwide Featured News Editorials Commentaries Expert Opinions Interviews Case Studies Company Profiles Editor´s Picks

Chinese Pharma Growth Almost Flat in Q2 as Government Heightens Cost Containment Chief Editor James Shen offers his monthly review of the Chinese healthcare sector with this issue's emphasis on interpreting recent pharmaceutical industry and market pe... (11/1/2018) How China Will Handle Its Trade War With the United States in 2019 (11/15/2018) CFIUS Broadens Coverage of Cross-Border Biotech Transactions (11/13/2018) China’s Crackdown on Genetics Breaches Could Deter Data Sharing (11/13/2018) In China, Desperate Patients Smuggle Drugs. Or Make Their Own. (11/12/2018) Production of Trustworthy Real World Data and Evidence in China (11/7/2018) Issues in Chinese Foreign Direct Investment in U.S. Early Stage Biotechnology Companies (11/2/2018) Chinese Pharma Growth Almost Flat in Q2 as Government Heightens Cost Containment (11/1/2018) Innovent Biologics Believes It Can Help Usher in A 'Game Changer' for Drug Prices in China (11/1/2018) Bispecific Antibodies in China (10/26/2018) Alibaba and JD.com Operate in Grey Area with Online Drug Sales (10/25/2018) Three Big Pharma Stocks Racing Along the Road to China (10/25/2018) China Is Funding the Future of American Biotech (10/23/2018) China's Pharmaceutical Firms Feel First Impact From Trump's Trade War (10/17/2018) Targeting the Affluent: Differential Access to Targeted Therapies in China (10/16/2018) How to Fulfil Chin'’s Potential for Carrying Out Clinical Trials (10/15/2018) NH Reports on Chinese OTC Eye Care Marke...  (11/19/2018) Eli Lilly Mulls Sale of Certain Off-pate...  (11/19/2018) NMPA Approves Gilead's Tenofovir Alafena...  (11/16/2018) Chi-Med Announces Negative Results of Ph...  (11/16/2018) NMPA Grants Priority Review to BeiGene's...  (11/16/2018) MorphoSys and I-Mab Enter Strategic Alli...  (11/15/2018) Catalent Invests in Its 2nd Clinical Sup...  (11/15/2018) (free) President Xi Pledges to Protect IP and B...  (11/15/2018) U.S. Trade Union Urges USFDA to Investig...  (11/14/2018) NMPA Issues Rules for Drug Export Sales ...  (11/13/2018) Angion Biomedica and Sinovant Enter Lice...  (11/12/2018) Yifan Subsidiary Announces Chinese IND A...  (11/12/2018) (free) Innovent Files Chinese NDA for Humira Bi...  (11/12/2018) Merck to Quadruple Gardasil Supply in Ch...  (11/12/2018) Leading MNCs Tout Renewed China Business...  (11/12/2018) Top 25 Global Pharmaceutical Companies by Market Cap 201... CANbridge Receives IND Approval to Commence CAN008 Phase... Global Contract Pharmaceutical Manufacturing Market to R... White House Task Force Echoes Pharma Proposals Pharma Industry Reputation Rebounds Somewhat in 2016 NH Reports on Chinese OTC Eye Care Market in MAT 09/2018 Faster Aging of Population Boosts China's Human Vaccine Industr... DB6: Chinese OTC Market Up 6.6% in MAT Q2/2018 IQVIA: Chinese Retail Pharmacy Market Surged 3.9% in MAT Q2/201... IQVIA: Chinese Hospital Drug Market Up 2.8% in MAT Q2/2018 Eli Lilly Mulls Sale of Certain Off-patent CNS and Antibioti... NMPA Approves Gilead's Tenofovir Alafenamide (TAF) in China MorphoSys and I-Mab Enter Strategic Alliance for MorphoSys's... Catalent Invests in Its 2nd Clinical Supply Facility in Shan... Merck to Quadruple Gardasil Supply in China to Meet Fast-ris... NMPA Issues Rules for Drug Export Sales Certificate SAMR Solicits Comments on Production Licensing Regulatio... NMPA Issues Guidelines for Clinical Trials of Mental and... NMPA Issues New Announcement (2018#86) for Clinical Data... Shanghai Promotes Biopharma Innovation with New Measures... President Xi Pledges to Protect IP and Boost Import at 1st I... U.S. Trade Union Urges USFDA to Investigate GNC Acquisition ... SAMR Solicits Comments on Vaccine Administration Law Chinese Lawyer Sues Yunnan Baiyao over False Advertising Genentech Accuses Former Employees of Stealing Drug Secrets ... Huahai Pharma Faces Lawsuits on Cancer-Causing Valsartan... Zheijiang Huahai Placed under Increased Supervision EU, U.S. and Canada Investigating Second Impurity in Hua... EU Regulators Issue Notice on a Chinese Anticancer API A... USFDA Recalls Thyroid Drugs Containing Chinese API over ... Chi-Med Announces Negative Results of Phase III Chinese ... NMPA Grants Priority Review to BeiGene's NDAs for Zanubr... Angion Biomedica and Sinovant Enter Licensing Deal to De... Yifan Subsidiary Announces Chinese IND Approval of Antic... Innovent Files Chinese NDA for Humira Biosimilar IBI303 Guangdong Introduces Implementation Plan for Generic Dru... China Step Up Crackdown on Medical Frauds by Charities China Step Up Crackdown on Medical Frauds by harities fa... China Aims to Train 500,000 Additional GPs by 2030 NHC Releases 2018 Edition of National Essential Drug Lis... Recent Executive Moves Recent Executive Moves SMIA Announces 17 Departmental Level Senior Official Appoi... Recent Executive Moves Top Chinese Pharma Tycoons Advance on Forbes China Rich Li... China to Launch New Tech Bourse in Shanghai Upcoming Event: 2nd International Conference on Vaccines... Upcoming Event: 31st Annual Cardiologists Conference Upcoming Event: Phar-East 2019 Upcoming Event: Health Insurance Innovation Congress Asi... Pharma China is the most influential English media and source of business intelligence covering the Chinese pharmaceutical and biopharmaceutical sector... WiCON has been helping international healthcare companies succeed in China and other Asian markets since 1991. We advise our clients on every stage of their China and Asian business. We worked with clients in many regions of the world...   WiCON Officially Publishes Chi...   WiCON Officially Publishes Chi...   WiCON and PharmaGuys Launch Ph...   WiCON Officially Publishes Chi...   WiCON Officially Publishes Its...

© Wicon International Group  Support by: www.heightow.com Site map | Contact Us | Links